Clene (CLNN)
(Delayed Data from NSDQ)
$6.11 USD
-0.24 (-3.78%)
Updated Nov 1, 2024 03:59 PM ET
After-Market: $6.11 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
CLNN 6.11 -0.24(-3.78%)
Will CLNN be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for CLNN based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CLNN
Wall Street Analysts Think Clene (CLNN) Could Surge 873.45%: Read This Before Placing a Bet
Wall Street Analysts Believe Clene (CLNN) Could Rally 976.32%: Here's is How to Trade
CLNN: What are Zacks experts saying now?
Zacks Private Portfolio Services
Clene Inc. (CLNN) Reports Q2 Loss, Lags Revenue Estimates
Clene Inc. (CLNN) Reports Q1 Loss, Lags Revenue Estimates
Puma Biotech (PBYI) Reports Q1 Loss, Tops Revenue Estimates
Other News for CLNN
Clene Unveils Phase 3 Trial Design at NEALS
Benchmark Co. Sticks to Their Buy Rating for Clene (CLNN)
Promising Outlook for Clene’s CNM-Au8 in ALS Treatment: A Comprehensive Buy Rating Rationale
Clene price target lowered by $8 at Canaccord, here's why
Insider Buying: Chief Science Officer Mark Mortenson Acquires Shares of Clene Inc (CLNN)